Canada - engleză - Health Canada

modern veterinary therapeutics llc - medetomidine hydrochloride - solution - 1mg - medetomidine hydrochloride 1mg - dogs

Israel - engleză - Ministry of Health

a.veterinary supply ltd - medetomidine hydrochloride - solution for injection - medetomidine hydrochloride 1 mg/ml - in dogs and cats: sedation to facilitate handling. premedication prior to general anaesthesia.in cats: in combination with ketamine for general anaesthesia for minor surgical procedures of short duration.

Nigeria - engleză - NAFDAC (National Agency for Food and Drugs Administration and Control)

cimetidine 200mg & 400mg

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

synthon bv - tamsulosin hydrochloride - modified-release capsule, hard - 400 microgram(s) - alpha-adrenoreceptor antagonists; tamsulosin - alfa
1-adrenoceptor antagonist - lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph).

Uniunea Europeană - engleză - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - drugs for obstructive airway diseases, - budesonide/formoterol teva is indicated in adults 18 years of age and older only.asthmabudesonide/formoterol teva is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists.orin patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.copdsymptomatic treatment of patients with severe copd (fev1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.

Uniunea Europeană - engleză - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol - asthma - drugs for obstructive airway diseases, - budesonide/formoterol teva pharma b.v. is indicated in adults 18 years of age and older only.asthmabudesonide/formoterol teva pharma b.v. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: orin patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists.in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists. 

Uniunea Europeană - engleză - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - drugs for obstructive airway diseases, - vylaer spiromax is indicated in adults 18 years of age and older only.asthmavylaer spiromax is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists.orin patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.copdsymptomatic treatment of patients with severe copd (fev1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.

Uniunea Europeană - engleză - EMA (European Medicines Agency)

recordati ireland ltd - silodosin - prostatic hyperplasia - urologicals, alpha-adrenoreceptor antagonists - treatment of the signs and symptoms of benign prostatic hyperplasia (bph) in adult men.

Uniunea Europeană - engleză - EMA (European Medicines Agency)

teva pharma b.v.  - budesonide, formoterol fumarate dihydrate - asthma; pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - budesonide/formoterol teva pharma b.v. is indicated in adults 18 years of age and older only.asthmabudesonide/formoterol teva pharma b.v. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate:-in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists.or-in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.copdsymptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev1) 

Uniunea Europeană - engleză - EMA (European Medicines Agency)

pierre fabre medicament - neratinib - breast neoplasms - antineoplastic agents - nerlynx is indicated for the extended adjuvant treatment of adult patients with early stage hormone receptor positive her2-overexpressed/amplified breast cancer and who are less than one year from the completion of prior adjuvant trastuzumab based therapy.